Product Introduction: BISONOL-2.5

BISONOL-2.5 is a low-dose cardioselective beta-blocker tablet manufactured by Knoll. Composed of 2.5mg of Bisoprolol Fumarate, this tablet is indicated for patients initiating antihypertensive therapy, elderly patients, or those starting stable chronic heart failure treatment. By slowing heart rate, it reduces cardiac workload and blood pressure.

Primary Indications

• Management of essential hypertension (high blood pressure).
• Treatment of chronic stable angina pectoris.
• Initial titration phase for stable chronic heart failure.

Therapeutic Benefits

• Gentle BP Regulation: Lower starting dose reduces the risk of initial dizziness and side effects.
• Cardioselective Action: High affinity for beta-1 receptors minimizes respiratory side effects.
• Cardiac Workload Reduction: Decreases cardiac strain, protecting against ischemic events.

Possible Side Effects

Common side effects may include:

• Bradycardia (slow heart rate) or cold extremities.
• Fatigue, dizziness, or headache.
• Mild gastrointestinal discomfort or muscle weakness.

How to Take BISONOL-2.5

• Take the tablet daily, preferably in the morning, with or without food.
• Swallow the tablet whole with water. Do not crush or chew.
• Do not stop taking the drug abruptly, as it can cause rebound hypertension or angina.

Mechanism of Action

BISONOL-2.5 contains Bisoprolol, which is a highly selective antagonist of beta-1 adrenergic receptors in the heart. It blocks the chronotropic and inotropic actions of catecholamines, leading to a decrease in heart rate, myocardial contractility, and cardiac output, lowering systemic blood pressure.

Safety Warnings

• Bradycardia: Monitor heart rate. Contraindicated in patients with cardiogenic shock or second-degree heart block.
• Asthma: Use with caution in patients with reactive airway disease, as selectivity is dose-dependent.
• Pregnancy & Nursing: Use only when clearly prescribed by a physician.

Patient Advice

• Avoid sudden changes in posture to prevent orthostatic dizziness.
• Monitor your heart rate regularly and report bradycardia below 50 bpm to your doctor.
• Maintain a low-sodium diet and a healthy lifestyle.

Fact Box

Drug Interactions

• Calcium Channel Blockers (Verapamil, Diltiazem): May lead to severe bradycardia or heart block.
• NSAIDs (Ibuprofen): Can reduce the antihypertensive effect.
• Insulin: Beta-blockers may mask symptoms of hypoglycemia (tachycardia).

User Feedback

• Patients report highly satisfactory blood pressure control, with minimal fatigue compared to older beta-blockers.
• Highly recommended by cardiologists for heart failure management.